Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

PURPOSE: Salvage chemotherapy followed by high-dose therapy and autologous stem-cell transplantation (ASCT) is the standard treatment for relapsed diffuse large B-cell lymphoma (DLBCL). Salvage regimens have never been compared; their efficacy in the rituximab era is unknown. PATIENTS AND METHODS: P...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Gisselbrecht, Christian, Glass, Bertram, Mounier, Nicolas, Singh Gill, Devinder, Linch, David C., Trneny, Marek, Bosly, Andre, Ketterer, Nicolas, Shpilberg, Ofer, Hagberg, Hans, Ma, David, Brière, Josette, Moskowitz, Craig H., Schmitz, Norbert
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2010
Aiheet:
Original Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3664033/
https://ncbi.nlm.nih.gov/pubmed/20660832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.28.1618
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia